Aviva’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,649
Closed -$3.46M 1035
2022
Q3
$3.46M Buy
25,649
+1,200
+5% +$206K 0.02% 625
2022
Q2
$3.96M Buy
24,449
+2,700
+12% +$422K 0.02% 630
2022
Q1
$4.1M Buy
21,749
+200
+0.9% +$42.5K 0.02% 626
2021
Q4
$5.84M Buy
21,549
+5,100
+31% +$1.72M 0.02% 545
2021
Q3
$5.97M Buy
16,449
+2,619
+19% +$856K 0.03% 530
2021
Q2
$4.75M Sell
13,830
-300
-2% -$99.4K 0.02% 604
2021
Q1
$4.92M Sell
14,130
-600
-4% -$199K 0.02% 538
2020
Q4
$3.81M Sell
14,730
-3,744
-20% -$1.03M 0.02% 552
2020
Q3
$5.29M Buy
18,474
+1,449
+9% +$341K 0.03% 436
2020
Q2
$3.21M Buy
17,025
+163
+1% +$26.5K 0.02% 521
2020
Q1
$2.08M Buy
16,862
+1,304
+8% +$204K 0.02% 725
2019
Q4
$2.58M Buy
15,558
+305
+2% +$50.7K 0.02% 612
2019
Q3
$1.87M Sell
15,253
-1,449
-9% -$192K 0.01% 656
2019
Q2
$2.07M Buy
16,702
+1,775
+12% +$225K 0.01% 651
2019
Q1
$1.97M Buy
14,927
+166
+1% +$22.4K 0.01% 657
2018
Q4
$2.07M Buy
+14,761
New +$1.96M 0.02% 627

Other funds holding ONC